Erucamide, also known as 13-docosenamide or (Z)-docos-13-enamide, is a primary fatty amide resulting from the formal condensation of the carboxy group of erucic acid with ammonia. Erucamide is used in plastics and the rubber industry, ink and paint industries, the food packaging industry and others. It is used principally as a slip additive, an antiblock agent, and for paper-coating compositions and waterproofing. Erucamide and some of its derivatives are approved for use in polymers at low concentration levels. At these levels, the material is effective without adversely affecting other physical characteristics of the polymer.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Erucamide, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’s OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.